Medtronic and New Milestone Hospital Group Announce Strategic Partnership to Advance Healthcare Innovation in China

On November 28, in Shanghai, Medtronic and New Journey Hospital Group held a signing ceremony for their strategic cooperation. Gu Yushao, Global Senior Vice President and President of Greater China at Medtronic, and Lin Yanglin, CEO of New Journey Hospital Group, signed the agreement on behalf of their respective parties.

△Gu Yushao, Senior Vice President of Medtronic and President of Greater China (second from right), and Lin Yanglin, CEO of New Journey Hospital Group (second from left), signed the agreement on behalf of their respective parties; Xiao Yindi, Vice President of Regional Growth Initiatives for Medtronic Greater China (first from right), and Tao Lin, General Manager of the Operations Management Department at New Journey Hospital Group (first from left), witnessed the signing.

Medtronic is a global leader in medical technology, and New Journey Hospital Group is one of the largest comprehensive hospital groups in China. This collaboration between the two parties represents a powerful alliance.

Gu Yushao stated, “The partnership between Medtronic and New Journey represents another endeavor in our exploration of diversified growth in the Chinese market. Looking ahead, Medtronic hopes to join hands with New Journey Group to collectively forge a ‘New Journey’ for China’s healthcare sector, create new industry highlights, and inject fresh vitality, ultimately alleviating suffering, restoring health, and extending lives for more patients.”

△Gu Yushao, Senior Vice President of Medtronic and President of Greater China, delivers remarks at the signing ceremony

Lin Yanglin stated that the collaboration with Medtronic spans multiple dimensions, including medical technology, talent training, “Internet+,” and seeking opportunities for cooperation in venture capital to jointly incubate new technologies. This represents an active exploration by both parties, guided by shared values, into China’s healthcare reform initiatives.

△Lin Yanglin, CEO of New Journey Hospital Group, delivers remarks at the signing ceremony

The collaboration between the two parties includes the following: First, both parties will jointly promote the implementation and application of Medtronic’s innovative therapies across multiple hospitals under the New Milestone Hospital Group, covering but not limited to the fields of cardiac and vascular diseases, neurological disorders, spinal conditions, cancer, and endocrinology, thereby improving the accessibility of these therapies and benefiting more patients in China.

Second, with the support of Medtronic’s clinical training system, New Journey Hospital Group will further empower its affiliated hospitals to improve discipline construction and the cultivation system for clinical talent pipelines.

Medtronic boasts world-class clinical training capabilities. In China, the Medtronic Shanghai Innovation Center has introduced cutting-edge clinical training facilities and has trained more than 50,000 surgeons to date. New Journey Hospital Group will collaborate with Medtronic to provide a more advanced, systematic, and diverse training framework for clinical professionals across its affiliated hospitals, thereby enhancing the clinical skills of medical staff and driving continuous improvement in the quality of healthcare services.

Third, Medtronic’s diabetes business has partnered with “Dingling Doctor,” the internet healthcare platform under New Horizon Hospital Group, leveraging Medtronic’s strengths in continuous glucose monitoring (CGM) products and Dingling Doctor’s channel advantages to strive for an “Internet+” model of diabetes disease management.

New Journey Hospital Group’s “Dingling Doctor” is built on a foundation of “brick-and-mortar medical institutions + internet hospitals.” Through the Dingling Doctor app, it focuses on online consultations for specialized and chronic diseases, tiered diagnosis and treatment, and offline DTP (Direct-to-Patient) pharmacies, thereby completing the “last mile” of “Internet + Healthcare.”

Meanwhile, both parties will explore collaboration between New Milestone Capital and Medtronic in the areas of venture capital and technology incubation, aiming to support emerging forces in China’s healthcare technology sector and uncover new growth drivers for the domestic medical technology industry.

In October 2019, New Journey Hospital Group initiated the establishment of New Journey Capital and launched a healthcare industry fund with a total size of RMB 10 billion and an initial closing of RMB 2 billion. The fund is dedicated to investing in high-quality projects in the broader health sector and in research achievements with leading advantages. By fully leveraging New Journey Hospital Group’s extensive offline medical traffic entry points and its industry-academia-research synergy in partnership with the University of Chinese Academy of Sciences, the fund provides broad application scenarios for high-quality global projects, comprehensively building a globally competitive healthcare ecosystem.

Within Medtronic’s global footprint, the Chinese market is experiencing rapid growth and holds immense potential. 2019 marked the 30th anniversary of Medtronic’s entry into China. As one of the first multinational medical technology companies to enter China in the early stages of its reform and opening-up policy, Medtronic has been both a witness to and an active participant in the development of China’s healthcare industry. Medtronic firmly believes that, driven by its large population, aging demographics, and rapid urbanization, China is destined to become the world’s largest healthcare market, with privately funded hospitals playing an increasingly vital role in this significant opportunity.

Lin Yanglin stated that New Journey Hospital Group has rapidly developed over the past few years into a large-scale healthcare group with more than 10,000 beds, focusing on addressing the production relations of traditional medical institutions through mixed-ownership reforms. This collaboration between New Journey and Medtronic will explore technological advancement and institutional liberation in traditional medical institutions from both productivity and production relations perspectives.

Medtronic, headquartered in Dublin, Ireland, is a global provider of medical technology, services, and solutions, dedicated to alleviating pain, restoring health, and extending life for millions of people worldwide. With more than 90,000 employees, Medtronic serves physicians, hospitals, and patients in over 150 countries and regions. Working hand in hand with partners around the globe, we jointly advance the development of healthcare.

New Century Healthcare Holding Group is one of the largest comprehensive hospital groups in China, serving as a reformer, leader, and innovator in social capital-driven healthcare. The group holds controlling interests in hospitals with a total bed capacity exceeding 10,000. Its business portfolio spans hospitals, elderly care, medical technology, and capital platforms. Upholding the vision of “ensuring access to better health services for all,” New Century Healthcare Holding Group is committed to becoming a respected enterprise in the broader health industry that harmonizes commercial value with social responsibility.